Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
venture capital (VC)
Biotech
TCGX launches $600M fund to bankroll Asian biotechs
Investment firm TCGX is expanding in Asia, raising $600 million to funnel into biotechs emerging from a burgeoning drug discovery hotspot.
Nick Paul Taylor
Oct 7, 2026 10:21am
Fierce Biotech Fundraising Tracker '26: KymaThera & more
Oct 6, 2026 10:15am
Luma locks down 15-year, $410M life sciences fund
Sep 9, 2026 9:43am
Epicrispr bags $90M to rewrite treatment of rare muscle disease
Aug 11, 2026 10:30am
Novo Holdings-backed Claris Bio emerges with $118M
Jul 28, 2026 8:00am
Thiel-backed CEO eyes $50M fundraise after bagging China drug
Jul 22, 2026 4:00am
